Clinical Trials Browser

Phase 2 × HER2 Insertion Mutation Positive Advanced NSCLC × pyrotinib × Clear all

NCT04144569 2024-09-19

PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC

Phase 2 Recruiting

HER2 Insertion Mutation Positive Advanced NSCLC